206 related articles for article (PubMed ID: 12913923)
41. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.
van der Helm-van Mil AH; Verpoort KN; Breedveld FC; Huizinga TW; Toes RE; de Vries RR
Arthritis Rheum; 2006 Apr; 54(4):1117-21. PubMed ID: 16572446
[TBL] [Abstract][Full Text] [Related]
42. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
43. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
Syversen SW; Gaarder PI; Goll GL; Ødegård S; Haavardsholm EA; Mowinckel P; van der Heijde D; Landewé R; Kvien TK
Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
[TBL] [Abstract][Full Text] [Related]
44. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.
Meyer O; Labarre C; Dougados M; Goupille P; Cantagrel A; Dubois A; Nicaise-Roland P; Sibilia J; Combe B
Ann Rheum Dis; 2003 Feb; 62(2):120-6. PubMed ID: 12525380
[TBL] [Abstract][Full Text] [Related]
45. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
Mouterde G; Lukas C; Goupille P; Flipo RM; Rincheval N; Daurès JP; Combe B
J Rheumatol; 2014 Aug; 41(8):1614-22. PubMed ID: 25028372
[TBL] [Abstract][Full Text] [Related]
46. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
Luban S; Li ZG
Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
[TBL] [Abstract][Full Text] [Related]
47. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis.
van Jaarsveld CH; ter Borg EJ; Jacobs JW; Schellekens GA; Gmelig-Meyling FH; van Booma-Frankfort C; de Jong BA; van Venrooij WJ; Bijlsma JW
Clin Exp Rheumatol; 1999; 17(6):689-97. PubMed ID: 10609067
[TBL] [Abstract][Full Text] [Related]
48. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.
Nell VP; Machold KP; Stamm TA; Eberl G; Heinzl H; Uffmann M; Smolen JS; Steiner G
Ann Rheum Dis; 2005 Dec; 64(12):1731-6. PubMed ID: 15878904
[TBL] [Abstract][Full Text] [Related]
49. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.
Al-Matar MJ; Petty RE; Tucker LB; Malleson PN; Schroeder ML; Cabral DA
Arthritis Rheum; 2002 Oct; 46(10):2708-15. PubMed ID: 12384930
[TBL] [Abstract][Full Text] [Related]
50. Profiling of rheumatoid arthritis associated autoantibodies.
Conrad K; Roggenbuck D; Reinhold D; Dörner T
Autoimmun Rev; 2010 Apr; 9(6):431-5. PubMed ID: 19932198
[TBL] [Abstract][Full Text] [Related]
51. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175
[No Abstract] [Full Text] [Related]
52. Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis.
Rantapää-Dahlqvist S; Boman K; Tarkowski A; Hallmans G
Ann Rheum Dis; 2007 Jan; 66(1):121-3. PubMed ID: 16740681
[TBL] [Abstract][Full Text] [Related]
53. All you wanted to know about anti-CCP but were afraid to ask.
Wiik AS; van Venrooij WJ; Pruijn GJ
Autoimmun Rev; 2010 Dec; 10(2):90-3. PubMed ID: 20727426
[TBL] [Abstract][Full Text] [Related]
54. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.
Farragher TM; Lunt M; Plant D; Bunn DK; Barton A; Symmons DP
Arthritis Care Res (Hoboken); 2010 May; 62(5):664-75. PubMed ID: 20461787
[TBL] [Abstract][Full Text] [Related]
55. Long-term stability of anti-cyclic citrullinated peptide antibody status in patients with early inflammatory polyarthritis.
Burr ML; Viatte S; Bukhari M; Plant D; Symmons DP; Thomson W; Barton A
Arthritis Res Ther; 2012 May; 14(3):R109. PubMed ID: 22571727
[TBL] [Abstract][Full Text] [Related]
56. Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.
Meyer O; Nicaise-Roland P; Santos MD; Labarre C; Dougados M; Goupille P; Cantagrel A; Sibilia J; Combe B
Arthritis Res Ther; 2006; 8(2):R40. PubMed ID: 16469118
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Sghiri R; Bouagina E; Zaglaoui H; Mestiri H; Harzallah L; Harrabi I; Ghannouchi M; Mokhtar F; Ghedira I
Rheumatol Int; 2007 Oct; 27(12):1125-30. PubMed ID: 17447069
[TBL] [Abstract][Full Text] [Related]
58. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.
van Gaalen FA; Linn-Rasker SP; van Venrooij WJ; de Jong BA; Breedveld FC; Verweij CL; Toes RE; Huizinga TW
Arthritis Rheum; 2004 Mar; 50(3):709-15. PubMed ID: 15022309
[TBL] [Abstract][Full Text] [Related]
59. Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease?
Taraborelli M; Inverardi F; Fredi M; Ceribelli A; Cavazzana I; Tincani A; Franceschini F
Reumatismo; 2012 Dec; 64(5):321-5. PubMed ID: 23256108
[TBL] [Abstract][Full Text] [Related]
60. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis.
Raza K; Breese M; Nightingale P; Kumar K; Potter T; Carruthers DM; Situnayake D; Gordon C; Buckley CD; Salmon M; Kitas GD
J Rheumatol; 2005 Feb; 32(2):231-8. PubMed ID: 15693082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
